AX-208

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAX-208
Drug Alias NameAX208
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlaucomaParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSygnis Bioscience Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGlaucomaParkinson DiseaseHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A